Development and validation of stability indication RP-HPLC method for estimation of satranidazole from its formulation
Shirode, A. R.
Development and validation of stability indication RP-HPLC method for estimation of satranidazole from its formulation - Vol. 55 (10) - Mumbai Indian Drug Manufacture's Association - IDMA 2018 - 40-48
A sensitive stability-indicating high performance liquid chromatography (HPLC) method was developed and validated for quantitative estimation of satranidazole (SAT), a new nitroimidazole with potent antiamoebic activity and accessible in market as tablet and dry syrup either alone or in combination with ofloxacin. The present study involves the development of simple, accurate, precise, reproducible reversed phase high performance liquid chromatography (RP-HPLC) method for determination of satranidazole from its formulation. Isocratic elution at a flow rate of 1.0 mL/min was employed on Hemochrom Intsil C-18 (250 mm× 4.6 mm, 5
PHARMACEUTICS
HPLC Satranidazole Marketed dosage form Stability studies ICH Forced degradations
Development and validation of stability indication RP-HPLC method for estimation of satranidazole from its formulation - Vol. 55 (10) - Mumbai Indian Drug Manufacture's Association - IDMA 2018 - 40-48
A sensitive stability-indicating high performance liquid chromatography (HPLC) method was developed and validated for quantitative estimation of satranidazole (SAT), a new nitroimidazole with potent antiamoebic activity and accessible in market as tablet and dry syrup either alone or in combination with ofloxacin. The present study involves the development of simple, accurate, precise, reproducible reversed phase high performance liquid chromatography (RP-HPLC) method for determination of satranidazole from its formulation. Isocratic elution at a flow rate of 1.0 mL/min was employed on Hemochrom Intsil C-18 (250 mm× 4.6 mm, 5
PHARMACEUTICS
HPLC Satranidazole Marketed dosage form Stability studies ICH Forced degradations